$WIX · Wix CEO says market misprices stock at 1.3x revenue despite $400M FCF and Base44 optionality

episode briefing

extracted intelligence

20VC

Wix Founder: What Wall St Gets Wrong About AI & Wix | Will Base44 Win the Vibe-Coding Wars?

now viewing▶ 4:30

Wix CEO says market misprices stock at 1.3x revenue despite $400M FCF and Base44 optionality

2026-07-13 · 8 company · 6 thematic

sentiment

6 bull0 bear2 neu

speakers

avishai abrahami

Avishai Abrahami co-founded Wix (NASDAQ: WIX), a $2.1B revenue website platform. He led the acquisition of Base44 (one-person company bought for $80M, now $150M+ ARR). He owns Atlassian shares, invested in K Health, and builds proprietary AI models for Wix and Base44.

quote

“Well, I think that's kind of a thing now with all SAS companies, right? Where the multiples went to [__] and I think a lot of it is is because the market don't know how to calculate the danger for SAS companies with AI. So, I I think that'…”

—avishai abrahami

now playing · $WIX

$BASE44bullish· high· posavishai abrahami

Base44 hits $150M+ ARR with 400 people; Wix investing $20M+ annually as AI-native dev platform

Base44 is growing rapidly as a vibe-coding platform for developers and agencies; Wix owns it and sees it as the future for customers who want custom software, while core Wix serve…

$WIX···bullish· high· posavishai abrahami

Wix CEO says market misprices stock at 1.3x revenue despite $400M FCF and Base44 optionality

Avishai argues the market assigns near-zero value to Wix's core business because it fears AI disruption, but SMB customers won't vibe-code complex business logic, and Base44 ($150…

$TEAM···neutral· medium· posavishai abrahami

Atlassian recovered but CEO worries developers will replace Jira with custom code

Avishai owns Atlassian shares and admits concern that developer customers could build their own ticketing workflows with AI, yet the stock recovered — suggesting he may be missing…

$K-HEALTHbullish· high· posavishai abrahami

K Health AI diagnoses better than most doctors; Avishai is investor

K Health has proven its AI diagnoses outperform physicians for common cases. Avishai distinguishes this from general LLM medical research, which he says hallucinates.

$CRM···bullish· mediumavishai abrahami

Salesforce trust moat makes it AI-resistant; CRM software is small part of value

Enterprise customers trust Salesforce with sensitive data; that trust is the real moat, not the CRM functionality. Vibe-coded agents cannot replicate the compliance and security g…

$MNDY···neutral· lowavishai abrahami

Monday.com CEO Eran Zinman unable to detach happiness from stock price unlike Avishai

Mentioned as a peer SaaS company; Avishai notes Eran Zinman struggles with stock volatility while he himself ignores it. No direct thesis on Monday's valuation.

$ISOMORPHIC-LABSbullish· mediumavishai abrahami

Isomorphic Labs and specialized AI firms will solve complex reasoning, not frontier LLMs

Frontier models lack capacity for true scientific simulation; specialized companies like Isomorphic Labs, Latent Labs, Chai Discovery that combine architectures will crack protein…

$FIG···bullish· mediumavishai abrahami

Figma earns near-religious devotion from designers; Avishai admires product quality

Figma's product understanding and quality create extreme user loyalty — designers use it for everything including grocery lists. Avishai respects this as a benchmark for product e…